General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
We're A Little Worried About InflaRx's (NASDAQ:IFRX) Cash Burn Rate | news.google.com • |
InflaRx (IFRX) Stock Up on FDA's EUA for COVID-19 Treatment | news.google.com • |
InflaRx (IFRX) Scheduled to Post Earnings on Wednesday | news.google.com • |
Raymond James & Associates Acquires 12873 Shares of InflaRx (NASDAQ:IFRX) | news.google.com • |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-05-08 | 2024-03 | -0.24 | N/A | N/A | N/A |
2024-03-21 | 2023-12 | -0.2 | -0.3 | -0.1 | -50.00% |
2023-11-01 | 2023-09 | -0.29 | -0.14 | 0.15 | 51.72% |
2023-11-01 | 2023-09 | -0.29 | N/A | N/A | N/A |
2023-08-10 | 2023-06 | -0.36 | N/A | N/A | N/A |
2023-08-10 | 2023-06 | -0.36 | -0.15 | 0.21 | 58.33% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-09-11 | HC Wainwright & Co. | Upgrade | Buy | Buy |
2023-08-30 | HC Wainwright & Co. | Upgrade | Buy | Buy |
2023-08-10 | HC Wainwright & Co. | Upgrade | Buy | Buy |
2023-05-11 | HC Wainwright & Co. | Upgrade | Buy | Buy |
2023-05-11 | Raymond James | Upgrade | Strong Buy | Strong Buy |
2023-04-20 | HC Wainwright & Co. | Upgrade | Buy |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Suvretta Capital Management, LLC | 5.73M | 25.57M | 12.83% |
2023-06-29 | Tang Capital Management, LLC | 2.90M | 12.93M | 6.49% |
2023-06-29 | 683 Capital Management LLC | 2.00M | 8.92M | 4.47% |
2023-06-29 | Eversept Partners, LP | 1.92M | 8.54M | 4.28% |
2023-06-29 | Point72 Asset Management, L.P. | 1.91M | 8.53M | 4.28% |
2023-06-29 | Morgan Stanley | 629.92K | 2.81M | 1.41% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-08-30 | Invesco ETF Tr-Invesco Raymond James SB-1 Equity ETF | 175.60K | 693.63K | 0.39% |
2023-05-30 | Fidelity NASDAQ Composite Index Fund | 26.33K | 110.31K | 0.06% |
2023-06-29 | ETF Managers Tr-ETFMG Treatments, Testing and Advancements ETF | 17.31K | 77.22K | 0.04% |
2023-08-30 | Invesco ETF Tr II-Invesco NASDAQ Future Gen 200 ETF | 8.27K | 32.67K | 0.02% |
Volume picking up positive news
Then why its can not cross 4.28 and volume is not that much which was expected in the morning
@Philip
May be you missed:
Despite underwhelming preliminary data from an earlier study, InflaRx (NASDAQ:IFRX) initiates Phase III trial evaluating IFX-1 in severe COVID-19-induced pneumonia, subject to regulatory approval
(SeekingAlpha.com)
12k volume, peanuts.
Get in quick
Going back up!!
Just bought another 1000 shares to avg down
$IFRX is at a dip! Buy now, this is a deal. The stock should multiply a couple times as it has a gap till $37. This is a huge breakthrough that helps treat CV
What should Percent should I set my Trailing stop at?
Earning day?